Header Logo

Connection

THOMAS TAYLOR to Cancer Vaccines

Back to Details
This is a "connection" page, showing publications THOMAS TAYLOR has written about Cancer Vaccines.
THOMAS TAYLOR
Connection Strength
0.208
Cancer Vaccines
  1. Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025 Dec; 21(1):2556591.
    View in: PubMed
    Score: 0.208
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.